Clinical Trial Update: Study of Efficacy and Safety of QAW039 in Patients With Severe Asthma Inadequately Controlled With Standard of Care Asthma Treatment. [Phase 3]

View source ↗

Summary

Phase 3 trial assessing efficacy and safety of QAW039 in severe asthma inadequately controlled with standard therapy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• QAW039

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2021-05-03